28.02.2013 Views

Traditional Medicine in Asia

Traditional Medicine in Asia

Traditional Medicine in Asia

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Traditional</strong> <strong>Medic<strong>in</strong>e</strong> <strong>in</strong> <strong>Asia</strong><br />

importance as they all have an impact on<br />

quality. For traditional medic<strong>in</strong>e to get a<br />

foothold on a susta<strong>in</strong>ed basis, the quality<br />

of the medic<strong>in</strong>e has to be assured. There is<br />

a world of difference between the efficacy<br />

of a medic<strong>in</strong>e made from plants cultivated<br />

and harvested us<strong>in</strong>g good agricultural<br />

practices and that derived from plants<br />

uprooted from the wild. 25<br />

In most countries, even <strong>in</strong> those where<br />

the use of traditional medic<strong>in</strong>e is strong,<br />

the cultivation of medic<strong>in</strong>al plants is at<br />

present limited to a few items, most natural<br />

products be<strong>in</strong>g collected by villagers and<br />

tribal people from wastelands and forests.<br />

For want of tra<strong>in</strong><strong>in</strong>g, they may destroy the<br />

whole plant <strong>in</strong>stead of collect<strong>in</strong>g just the<br />

part to be used. Re-plantation and<br />

propagation is left to nature. Collection not<br />

done dur<strong>in</strong>g the proper season often<br />

detracts from the efficacy of the end<br />

product. The network<strong>in</strong>g of collection is<br />

under the control of traders and the<br />

material collected is sold <strong>in</strong> the nearby<br />

township from where it reaches regional<br />

centres for domestic use or export. Enlightened<br />

<strong>in</strong>dustries do, however, cultivate<br />

plants so as to be assured of standard<br />

quality and the presence of active<br />

<strong>in</strong>gredients. They have <strong>in</strong>vested <strong>in</strong> recruit<strong>in</strong>g<br />

botanists and standardization experts <strong>in</strong><br />

order to access quality raw material. Some<br />

of these <strong>in</strong>dustries have their own R&D<br />

facilities where documentation is<br />

ma<strong>in</strong>ta<strong>in</strong>ed and quality assured through<br />

f<strong>in</strong>ger pr<strong>in</strong>t<strong>in</strong>g, HPLC and TLC tests.<br />

However, small manufactur<strong>in</strong>g <strong>in</strong>dustries<br />

rely on market sources which have many<br />

attendant problems which affect quality.<br />

In India, at the federal level the<br />

Departments <strong>in</strong> charge of traditional<br />

medic<strong>in</strong>e (Indian Systems of <strong>Medic<strong>in</strong>e</strong> and<br />

Homoeopathy under the M<strong>in</strong>istry of Health<br />

and Family Welfare), the Department of<br />

Environment and Forests, Agriculture,<br />

142<br />

Biotechnology, Science & Technology and<br />

Commerce have come together to evolve<br />

a coord<strong>in</strong>ated approach to the development<br />

of the medic<strong>in</strong>al plant sector. A<br />

Medic<strong>in</strong>al Plant Board has been established<br />

to coord<strong>in</strong>ate all the activities under<br />

the Department of Indian Systems of<br />

<strong>Medic<strong>in</strong>e</strong> and Homoeopathy which also<br />

has the responsibility to lay down standards<br />

for traditional medic<strong>in</strong>e drugs. Despite this<br />

policy-level support, the role of traditional<br />

medic<strong>in</strong>e <strong>in</strong> the health system will be<br />

decided by only one factor, i.e., the cur<strong>in</strong>g<br />

and health-giv<strong>in</strong>g ability of the practitioners<br />

and the remedies on a susta<strong>in</strong>ed basis.<br />

Standardization, a Pre-requisite<br />

for Quality Control of <strong>Traditional</strong><br />

<strong>Medic<strong>in</strong>e</strong> Drugs<br />

Standardization of plant-based drugs is<br />

extremely difficult because presently very few<br />

quality control tests are available <strong>in</strong> most<br />

countries us<strong>in</strong>g traditional medic<strong>in</strong>e. In their<br />

absence, there are no methods to evaluate<br />

the contents and the quantities as claimed<br />

on the label. Quality control is required at<br />

three stages, namely, when the raw material<br />

is used, for confirm<strong>in</strong>g the process<br />

undergone by the drug dur<strong>in</strong>g manufacture,<br />

and at the f<strong>in</strong>ish<strong>in</strong>g stage. The shelf-life or<br />

date of expiry needs to be <strong>in</strong>dicated and the<br />

possibility of mix<strong>in</strong>g modern drugs has to<br />

be strictly elim<strong>in</strong>ated and strong deterrents<br />

imposed to discourage such practices.<br />

Measures to test the absence of pesticide<br />

residues, heavy metals and aflatox<strong>in</strong> have<br />

to be taken through proper regulation and<br />

test<strong>in</strong>g. 26, 27 At least a few important markers<br />

have to be identified through TLC (f<strong>in</strong>ger<br />

pr<strong>in</strong>t<strong>in</strong>g) and the process of mak<strong>in</strong>g random<br />

checks has to be <strong>in</strong>stitutionalized and<br />

penalties imposed if non-permissible<br />

substances are found or the medic<strong>in</strong>e does<br />

not conform to safety standards. For patent<br />

proprietary drugs, manufacturers must be

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!